The coronary circulation in cardiac hypertrophy
- PMID: 7508057
The coronary circulation in cardiac hypertrophy
Abstract
Left ventricular hypertrophy is a common and important risk factor for cardiac mortality and morbidity. Cardiac hypertrophy adversely affects coronary perfusion because hypertension, its most frequent cause, is a major risk factor for coronary disease, and because cardiac hypertrophy may be associated with myocardial ischemia even in the absence of atheromatous coronary disease due to disturbances in coronary physiology. Several studies have demonstrated impairment of coronary reserve in human and experimental cardiac hypertrophy. Normal autoregulation of coronary flow may be disturbed in cardiac hypertrophy for many reasons, including (a) increased perfusion pressure in hypertension, (b) increased diastolic and systolic left ventricular pressures, in addition to disturbed coronary physiology. Studies undertake in the presence of maximal coronary vasodilatation indicate an increased minimal coronary vascular resistance in hypertrophied hearts. Because such measurements were determined in the presence of maximal coronary vasodilation, they are likely to indicate a reduced arteriolar lumenal cross-sectional area per unit mass of tissue. Studies of cardiac and coronary morphology support an imbalance in myocardial and coronary growth in cardiac hypertrophy, but further evidence is needed to confirm this. Myocardial contraction impairs coronary flow, and available evidence suggests that this systolic impairment may be greater in hypertrophied myocardium, and that this may be an additional factor in limiting coronary flow in hypertrophy. A further important feature of impaired coronary reserve in cardiac hypertrophy is its distribution. Studies using radiolabeled microspheres indicate that coronary reserve is reduced in endocardial regions to a much greater extent than epicardial regions. Previously, treatment of conditions such as hypertension, which are commonly associated with hypertrophy, have concentrated on correction of the main defect. It is important to bear in mind, however, that such treatments may have direct and indirect effects on the coronary circulation, which may have an important bearing on preserving myocardial function. An important aspect of future research will be to determine the effects of treatment on coronary perfusion.
Similar articles
-
Regulation of coronary blood flow during exercise.Physiol Rev. 2008 Jul;88(3):1009-86. doi: 10.1152/physrev.00045.2006. Physiol Rev. 2008. PMID: 18626066 Review.
-
Left ventricular pressure overload during postnatal development. Effects on coronary vasodilator reserve and tolerance to hypothermic global ischemia.J Thorac Cardiovasc Surg. 1993 Jan;105(1):120-31. J Thorac Cardiovasc Surg. 1993. PMID: 8419692
-
Alterations in the coronary circulation in hypertrophied ventricles.Circulation. 1987 Jan;75(1 Pt 2):I19-25. Circulation. 1987. PMID: 2947748 Review.
-
Coronary vascular changes in the progression and regression of hypertensive heart disease.J Cardiovasc Pharmacol. 1991;18 Suppl 3:S20-7. J Cardiovasc Pharmacol. 1991. PMID: 1720480
-
Comparative analysis of cardiac function, geometry, energetics and coronary reserve in hypertensive heart disease.Nephron. 1987;47 Suppl 1:76-86. doi: 10.1159/000184559. Nephron. 1987. PMID: 2962004
Cited by
-
Coronary flow reserve impairment in apical vs asymmetrical septal hypertrophic cardiomyopathy.Clin Cardiol. 2013 Apr;36(4):207-16. doi: 10.1002/clc.22095. Epub 2013 Feb 3. Clin Cardiol. 2013. PMID: 23378014 Free PMC article.
-
Pharmacological properties of indapamide. Rationale for use in hypertension.Clin Pharmacokinet. 1999;37 Suppl 1:7-12. doi: 10.2165/00003088-199937001-00002. Clin Pharmacokinet. 1999. PMID: 10491728 Review.